Dr. Joshua Brandstadter is a physician-scientist and Instructor of Medicine in the Division of Hematology/Oncology at the University of Pennsylvania. As Director of Clinical Research for the CSTL, Dr. Brandstadter oversees the ACCERLERATE Natural History Registry to better understand patient experiences and the comparative effectiveness of different treatments. He cares for patients with Castleman Disease in clinic and pursues laboratory research to better understand the causes of the disease. Dr. Brandstadter holds an MSc in Integrated Immunology from the University of Oxford and a combined MD/PhD from Duke University. He completed his internal medicine and hematology/oncology training at the Hospital of the University of Pennsylvania.